Diagnostics
-
The Cautionary Tale of Ivermectin: Consequences of Flawed Research
Written by: Akshara Ramasamy Edited by: Esther Melamed The global desire for COVID-19 preventive and therapeutic treatment options has resulted in a demand for both randomized clinical studies and systematic analysis of such studies. However, this high demand for information has also led to data presentation/publications of varying quality via publication channels that may or may…
-
Blood oxygen level-dependent activation of the orbitofrontal cortex in COVID-19
Written by: Parker Davis Edited by: Esther Melamed Anosmia and ageusia – a loss of the sense of smell and taste, respectively – are well-documented symptoms of infection by SARS-CoV-2, the agent of COVID-19 (Vaira et al., 2020; Mak et al., 2020; Tanasa et al., 2020). Though the origins of these symptoms were initially somewhat mysterious,…
-
First at-home diagnostic test kit and understanding false-negative tests
Written by: Apoorva Kakkilaya Edited by: Esther Melamed On November 17, 2020, the FDA issued its first emergency use authorization (EUA) for a self-test kit that can be administered entirely at home. The Lucira COVID-19 All-In-One Test Kit utilizes RT-LAMP technology to detect SARS-CoV-2 RNA from self-collected nasal swab samples. Swabs are placed in an…